title: Eosinophilia with aberrant T cells and elevated serum levels of interleukin-2 and interleukin-15.
authors.affiliation: Department of Medicine, National Naval Medical Center, Bethesda, MD, USA.
authors.forename: M
authors.initials: M
authors.lastname: Means-Markwell
authors.forename: T
authors.initials: T
authors.lastname: Burgess
authors.forename: D
authors.initials: D
authors.lastname: deKeratry
authors.forename: K
authors.initials: K
authors.lastname: O'Neil
authors.forename: J
authors.initials: J
authors.lastname: Mascola
authors.forename: T
authors.initials: T
authors.lastname: Fleisher
authors.forename: D
authors.initials: D
authors.lastname: Lucey
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004417:Dyspnea / Q000209:etiology; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D017681:Hypereosinophilic Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D019409:Interleukin-15 / Q000097:blood*; D007376:Interleukin-2 / Q000097:blood*; D007694:Killer Cells, Natural; D008297:Male; D010490:Pericardial Effusion / Q000209:etiology; D010641:Phenotype; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000970:Antineoplastic Agents; D019409:Interleukin-15; D007376:Interleukin-2; D006918:Hydroxyurea